Catalyst Wire Dossier Catalyst Wire Dossier

mesalamine pellet formulation

mesalamine · Bausch Health Americas, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for mesalamine pellet formulation, covering 2019-11-27 to 2019-11-27. Get the full timeline:

Most recent: Clinical Trial Update: Mesalamine Pellet Formulation to Maintain Remission of Mild to Moderate Ulcerative Colitis [Phase 3]

See pricing